11 Apr Peptides news Posted by admin 0 comments Best peptide for weight loss – retatrutide Best peptide for weight loss - retatrutide Through 26 experiments, a study involving 15500 participants showed that retatrutide is bes... Continue reading
21 Feb Peptides news Posted by admin 0 comments Hypoglycemic version of semaglutide cause blindness? Novo Nordisk: Very few confirmed cases Semaglutide cause blindness? Recently, a research paper published in the Journal of the American Medical Association Ophthalmology poin... Continue reading
18 Oct Peptides news Posted by admin 0 comments Semaglutide can effectively reduce subcutaneous and visceral fat Recent studies have found that GLP-1 drugs such as semaglutide can effectively reduce subcutaneous and visceral fat Through CT scannin... Continue reading
10 Oct Peptides news Posted by admin 0 comments Why was there the initial concept of “supplementing NAD+for life extension”? What is NAD+ life extension nad cell regenerator? NAD+, full name nicotinamide adenine dinucleotide. It always called life extension n... Continue reading
26 Sep Peptides news Posted by admin 0 comments Ozempic for heart patients: semaglutide orevent heart attack and stroke What the results of ozempic for heart patients? Recently, weight loss drugs such as semaglutide and tirzepatide have been proven to hav... Continue reading
05 Sep Peptides news Posted by admin 0 comments Semaglutide can delay aging? Yale University professor claims that semaglutide can delay aging The research results released at the European Society of Cardiology ... Continue reading
29 Jul Peptides news Posted by admin 0 comments Semaglutide update label to reflect risk reduction of MACE Semaglutide new indication to reflect risk reduction of MACE has been approved by the European Medicines Agency On July 25, 2024, th... Continue reading
09 Jul Peptides news Posted by admin 0 comments Lilly once again achieved success! The strongest weight loss drug with three targets – Retatrutide Retatrutide is a triple agonist of GCG/GIP/GLP-1 receptor developed by Lilly. In the phase II clinical trial for obese people without d... Continue reading
21 Jun Peptides news Posted by admin 0 comments Novo Nordisk launches Phase 3 clinical trials of CagriSema, prioritizing the development of weight loss indications, significantly superior to Semaglutide CagriSema Phase 3 clinical trials launched in China On July 5, 2023, Pharmaceuticals observed that according to the China Drug Clinica... Continue reading
11 Jun Peptides news Posted by admin 0 comments Semaglutide cause fatigue? How to solve it? Semaglutide cause fatigue? Today we are going to talk about the possible problems in the use of semaglutide - fatigue. As a drug, semag... Continue reading